Stephanie Kreis

6 Avenue Du Swing
Belvaux, ES L4367, Luxembourg

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Targeting store-operated Ca2+ entry as a novel strategy to overcome treatment resistance in melanoma.

Targeting store-operated Ca2+ entry as a novel strategy to overcome treatment resistance in melanoma.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: September 24, 2025

Targeting store-operated Ca2+ entry as a novel strategy to overcome treatment resistance in melanoma.

Targeting store-operated Ca2+ entry as a novel strategy to overcome treatment resistance in melanoma.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: September 24, 2025

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma.

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 27, 2025

Protocol to generate scaffold-free, multicomponent 3D melanoma spheroid models for preclinical drug testing.

Protocol to generate scaffold-free, multicomponent 3D melanoma spheroid models for preclinical drug testing.

Journal: STAR protocols

Published: February 01, 2024

A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma.

A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma.

Journal: Cell death & disease

Published: July 19, 2023

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.

Journal: Cancer gene therapy

Published: March 24, 2023

Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes.

Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes.

Journal: Journal of extracellular vesicles

Published: March 16, 2023

Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.

Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.

Journal: Cell reports

Published: November 30, 2022

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Journal: Cell death & disease

Published: October 03, 2022

MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression.

MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression.

Journal: Frontiers in cell and developmental biology

Published: August 01, 2022

Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

Journal: International journal of molecular sciences

Published: May 07, 2021

Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.

Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.

Journal: Cancers

Published: January 26, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026